Medicamen Biotech has entered into long term agreement with Vital Pharma Nordic, a Denmark based company, for CDMO (contract development and manufacturing company) for multiple products. Vital Pharma Nordic (VPN) is led by highly experienced specialists and engaged in licensing, development, distribution and sales of specialty Gx pharmaceuticals. VPN operate in the Nordic region now expanding internationally.
Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.
